Won the Ministry of Health and Welfare's Best Venture Capital House award at the 2026 Korea Venture Capital Awards for its biotech/healthcare investment track record.
Best Venture Capital House — 2026 Korea Venture Capital Awards
Achieved soft cap on a new venture fund targeting ₩280-300 billion ($197-211M), backed by IBK, KDB, KTCU, Korea Post, and MG Community Credit Cooperative, focused on deep-tech, biotech, and ICT.